GlaxoSmithKline to pay $3bn in US drug fraud scandal

medication Avandia is one of the three drugs concerned in the fraud case

GlaxoSmithKline (GSK) is to pay $3bn (£1.9bn) in the largest healthcare fraud settlement in US history.

The drug giant is to plead guilty to promoting two drugs for unapproved uses and failing to report safety data about a diabetes drug to the Food and Drug Administration (FDA).

The settlement will cover criminal fines as well as civil settlements with the federal and state governments.

The case concerns the drugs Paxil, Wellbutrin and Avandia.

Read More:

http://www.bbc.co.uk/news/world-us-canada-18673220